News zum Sektor Gesundheit aus Hong Kong (China)

 

MU, UNH and SJM highlight recent gains across Zacks portfolios as the firm showcases performance amid mixed markets....

FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of Invesco Ltd. discloser: (b) Owner or   controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and...

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

BofAS published a research report stating that active licensing transactions in China's pharmaceutical industry, together with companies' continued advancement in R&D innovation, will support a valuation re-rating of the sector.CSPC PHARMA (01093.HK) recently announced a cooperation agreement with AstraZeneca PLC Ordinary Shares......

FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of Invesco Ltd. discloser: (b) Owner or   controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and...

BofAS published a report stating that last Thursday (2nd), CSPC PHARMA (01093.HK) announced the signing of a collaboration agreement with AstraZeneca PLC Ordinary Shares (AZN.US), which will leverage CSPC PHARMA's siRNA drug discovery and extrahepatic targeted delivery platform. The two parties will jointly develop preclinical d......

FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of Invesco Ltd. discloser: (b) Owner or   controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and...

Wall Street expects sales to soar as several commercial launches approach....

VibroSense Dynamics AB (publ) has initiated legal proceedings to address a breach of the exclusive agreement signed with VibroSense's Chinese distributor Genertec Universal Medical Group Co., Ltd (UMCare), a subsidiary of General Technology (Group) Holding Co., Ltd. UMCare is listed on the Hong Kong Stock Exchange. Under the agreement, UMCare committed to placing orders totaling 3.74 MEUR over three years, starting from the date VibroSense received the NMPA Certificate (National Medical Product Administration) from the Chinese regulatory authority. In the agreement, the order amount is...

LUYE PHARMA (02186.HK) announced that the early redemption of the USD180 million 6.25% convertible bonds due 2028 has been completed, and all outstanding bonds have been redeemed and cancelled. As a result, there are no outstanding bonds in issue.Accordingly, the company has applied to The Stock Exchange of Hong Kong Limited for......

INDIANAPOLIS (dpa-AFX) - DKSH Holding AG (DKSH.SW, DKSH), a Swiss market expansion services provider, on Monday has entered into a distribution and promotion agreement with Eli Lilly and Co. (LLY)......

CSPC PHARMA (01093.HK) opened 3.58% higher today and once peaked at HKD8.05. It last stood at HKD8.03, up 6.36%, with turnover of 16.3348 million shares, involving HKD130 million.CSPC PHARMA announced that it entered into a collaboration, option and license agreement with AstraZeneca (AZN.US) to establish a strategic research co......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CSPC PHARMA (01093.HK) announced that it entered into a collaboration, option and license agreement with AstraZeneca (AZN.US) to establish a strategic research collaboration and utilise the Group’s proprietary siRNA drug discovery platform and extrahepatic targeted delivery platform to develop novel small nucleic acid drug......

Junshi Biosciences and Fosun Wanbang will cooperate on the development and commercialization of roconkibart in the Greater China Region....

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2026 on Thursday, July 30, 2026 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT)....

At midday close, HSI dropped 273 pts or 1.2% to 22,752. HSTI rose 61 pts or 1.4% to 4,454. HSCEI fell 98 pts or 1.3% to 7,507.Active Heavyweights:CCB (00939.HK) closed at $7.99, down 3%XIAOMI (01810.HK) closed at $21.54, down 1.5%BABA (09988.HK) closed at $92.35, down 0.7%MEITUAN (03690.HK) closed at $67.95, up 0.4%TENCENT (0070......

The world's largest buyer of biopharmaceutical royalties has set up its first Asia-Pacific base in Hong Kong, joining a string of multinational corporations in the pharmaceutical sector establishing offices in the city as out-licensing deals by mainland Chinese biotechnology firms hit record highs. Royalty financing gives drug developers an alternative way to raise capital even as US investment restrictions loom, according to an expert. “Chinese biotech firms would need royalty financing as an......

At close, HSI rose 354 pts or 1.6% to 23,026. HSTI rose 137 pts or 3.2% to 4,393. HSCEI gained 144 pts or 1.9% to 7,605. Market turnover reached $315.38 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $67.65, up 5.3%BABA (09988.HK) closed at $93, up 3.9%XIAOMI (01810.HK) closed at $21.86, up 2.1%TENCENT (00700.HK) close......

CSPC PHARMA (01093.HK) announced that the Phase III clinical study in China of SYS6010 developed by the Group in combination with Enlangsubai Monoclonal Antibody for the treatment of driver gene-negative non-small cell lung cancer (NSCLC) has been officially initiated. The first patient enrollment is planned to be completed in J......